Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 27, 2023 07:00 ET | Source: Forcefield Therapeutics

Forcefield Therapeutics appoints John Tsai MD as Chief Executive Officer

John will lead the company as CEO to explore the potential of a novel therapeutic for treatment of acute heart attacks into clinical developmentThis novel protein technology has been shown in...
April 04, 2023 07:00 ET | Source: Forcefield Therapeutics

Forcefield Therapeutics signs exclusive patent and know-how license agreement with Freeline Therapeutics

Forcefield Therapeutics signs exclusive patent and know-how license agreement with Freeline Therapeutics Agreement grants Freeline rights to develop and commercialise AAV gene therapies using cardiac...
November 07, 2022 07:00 ET | Source: Forcefield Therapeutics

Forcefield Therapeutics presents positive preclinical data at the 2022 Scientific Sessions of American Heart Association

Forcefield Therapeutics presents positive preclinical data at the 2022 Scientific Sessions of American Heart Association Preclinical data outlining the mechanisms of three proteins shown to restore...
August 31, 2022 14:00 ET | Source: Forcefield Therapeutics

Researchers identify three proteins which have the potential to prevent heart failure after heart attack

Researchers identify three proteins which have the potential to prevent heart failure after heart attack Publication in Science Translational Medicine describes three proteins which have been shown...
April 25, 2022 02:00 ET | Source: Forcefield Therapeutics

Forcefield Therapeutics launches today following £5.5m commitment from Syncona

Forcefield Therapeutics launches today following £5.5m commitment from Syncona New biotechnology company launched to develop pioneering, best-in-class therapeutics to protect heart function...